Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Medical Properties Trust stock has fallen about 68.3% over the past five years, yet the latest valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both suggest the shares may now be trading at a discount. After a recent pullback, investors are weighing whether the current price reflects ongoing concerns about tenants and balance sheet risk or an opportunity if the fundamentals hold up.
-
The share price decline of about 68.3% over five years highlights how much sentiment has reset and why current levels are being closely re assessed against fundamentals.
-
Recent refinancing activity and planned asset sales can support cash flow and debt reduction, while ongoing questions about tenant credit quality and the Norwood Hospital situation may keep a lid on how much value the market is willing to assign.
-
On Simply Wall St's broader checks, Medical Properties Trust screens as undervalued in 5 of 6 valuation tests , which leans toward the stock looking cheap on the current data set.
The issue now is whether Medical Properties Trust's recent share price weakness already reflects these risks or if the intrinsic value estimate and other checks point to a margin of safety that the market is overlooking.
Find out why Medical Properties Trust's 10.6% return over the last year is lagging behind its peers.
Is Medical Properties Trust a Bargain on Cash Flow?
The intrinsic value estimate for Medical Properties Trust comes from a Discounted Cash Flow (DCF) model based on adjusted funds from operations. On the latest data, the company is generating trailing twelve month free cash flow of about $183.9 million in $ and the model assumes that cash flows grow from here rather than shrink.
Under these assumptions, the DCF model points to an estimated intrinsic value of about $7.29 per share, which implies the stock screens as roughly 43.1% undervalued against the current market price. The recent Q2 2026 refinancing and planned asset sales help explain why the cash flow outlook used in this model remains supportive, even though the share price reaction has been weak.
On this DCF view, Medical Properties Trust stock appears undervalued relative to the cash flows implied by the current fundamentals.
Our Discounted Cash Flow (DCF) analysis suggests Medical Properties Trust is undervalued by 43.1%. Track this in your watchlist or portfolio , or discover 51 more high quality undervalued stocks .
Does Medical Properties Trust Look Undervalued on Sales?
P/S is a useful lens for Medical Properties Trust because revenue is a key reference point for many REIT investors when earnings and funds from operations can be noisy.
Medical Properties Trust currently trades on a P/S of about 2.3x, which sits well below the Health Care REITs industry average of about 6.6x and a peer average of about 5.6x. The tailored fair P/S ratio for the company is about 6.6x, indicating what investors might typically pay given its size, sector, margins and risk profile. That fair multiple is almost three times the current level.
This gap indicates the market is assigning a sizeable discount to Medical Properties Trust relative to sector norms despite revenue support from its hospital portfolio. While that discount may partly reflect concerns about tenant quality and balance sheet risk, the figures suggest a valuation that incorporates a high degree of caution.
On the P/S multiple, Medical Properties Trust stock currently appears undervalued compared with what its revenue profile and sector benchmarks would usually imply.
See what the numbers say about this price — find out in our valuation breakdown.
The Medical Properties Trust Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Medical Properties Trust pick up where the valuation checks leave off and focus on the story that would need to play out for the stock to be worth materially more or materially less than where it trades today, based on future growth, margins and earnings. Instead of a single ratio or model output, they present the full set of assumptions behind that figure so you can track whether Medical Properties Trust's reality is matching the scenario on the Community page.
One of the top community narratives on Medical Properties Trust: 48% undervalued
"Bullish analysts covering Medical Properties Trust have generally framed the reaffirmed US$8.00 price target as consistent with their updated assumptions on revenue, margins, and the future P/E multiple…"
Read one of the top narratives on Medical Properties Trust
Do you think there's more to the story for Medical Properties Trust? Head over to our Community to see what others are saying!
The Bottom Line
For Medical Properties Trust, both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples point to the stock looking undervalued on the current data. The broader valuation checks are also supportive, which means the market is already pricing in a good amount of caution around tenant risk and the balance sheet. From here, the key question is whether rental income and refinancing progress are steady enough for that discount to narrow, or whether those risks prove persistent and keep the stock in value trap territory.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MPT .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
